Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
about
Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?Glycemic variability and glycemic control in the acutely ill cardiac patientGlycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysisCongestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementAfter avandia: the use of antidiabetic drugs in patients with heart failurePrognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysisHeart Failure: a Major Cardiovascular Complication of Diabetes MellitusThe Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureDose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research DatabaseThe HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies.No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetesInpatient HbA1c testing: a prospective observational study.Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failureThe U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life.Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure TrialComorbid Heart Failure and Renal Impairment: Epidemiology and Management.Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial.Educational needs for improving self-care in heart failure patients with diabetesThe relationship between HbA₁c and ultrasound plaque textures in atherosclerotic patientsCoronary artery calcium: a clue to the enigma of tight glycemic control and cardiovascular disease?The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization.The effect of frailty should be considered in the management plan of older people with Type 2 diabetes.Energetics and metabolism in the failing heart: important but poorly understood.Cardiogenic diabetes.Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity.Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.Type 2 Diabetes and Heart Failure: Challenges and Solutions.Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.Insulin sensitizers and heart failure: an engine flooded with fuel.Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease.Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and Sex.Elevated serum glucose levels and survival after acute heart failure: a population-based perspective.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.Different levels of glycosylated hemoglobin influence severity and long-term prognosis of coronary heart disease patients with stent implantation.Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?
P2860
Q26799903-DA00F87C-7437-4BCE-9710-3616D4DB0C75Q26821994-1B52453D-2C91-403A-B272-1ACA77BCD8ADQ26860467-9AA46B15-71AC-4278-A924-4B8516275FB8Q27003819-A1C489EB-97EE-4C7E-B905-55E9B462CB58Q27021166-A6513382-4C10-45F9-9E70-472689C80A4DQ27021243-B5A52D1A-D030-4499-878C-796EC03B940AQ28066310-1A327456-4CA9-4ACE-8940-61C276FE2689Q28082343-4EB4328F-A9D9-4D9C-A9BA-E34036AB6FF3Q33815573-E335ADC3-39E6-49BE-A49D-095AA0A75427Q33873040-2F4E2F64-83C9-4B0E-AA84-BD98F45FC719Q35025208-E5C20BD1-BC5E-480E-98A5-09E0520CE4D3Q35420896-5F173A42-931B-470A-BC48-29E91CF6544DQ36007665-80FF0BED-BBB0-40A6-AD6D-72BBAA180859Q36024363-A090CDEC-8794-4234-8116-1248FAD394DFQ36053616-A0FE9641-9A4F-4C5B-92A5-CB4B73415EF1Q36421410-CDA1BD4B-25AE-4BE0-886B-1340679B6338Q36467465-443A0621-46D5-463B-9237-E8B191828B69Q36477865-A24271D6-27A9-45E7-8312-C4D669613039Q36551356-F010205C-3DF0-44A8-9EBE-06E0FCBBA2E9Q36765350-7DB3C526-A2C3-4A92-A780-9ECA5F540B4DQ36833645-E739A06E-4421-403C-B7BC-4A87EB344D0CQ37106132-9DA5B321-3A35-496F-AFED-F0EF73416215Q37400777-8E18B53A-03A0-4464-9E92-65A1035D1BF6Q37403177-C1453954-D31E-41F9-90D2-616D0F204A42Q37474232-4E0410EF-74A9-4A6B-B62E-E4BF9E066796Q37746834-F1D623C9-E87C-41D5-88FC-03B9B435BE20Q38156709-BC5CBD4B-B8A7-4BBE-878B-31236CCE121FQ38213328-DB0DA5BB-B695-4C54-B874-EA5A5F29B967Q38374511-87CB545E-9E28-40D7-9D2C-DF11C9321516Q38859858-40CFCC8D-D45E-447B-A79C-5CA3FB4EA112Q38960765-02BC0F8C-DEBE-49A1-A80D-36FE7D2D776BQ39461956-BB6C2893-101B-4F78-9814-4362FCA26F96Q39892657-C0EB7460-5659-4C64-BCAA-8CEE68038981Q41054147-BB150694-772C-4BF3-8E43-130224D42225Q41644888-368959D2-EA94-4674-AA55-3ACA78B4D6AAQ41668688-596292C3-3E2F-4133-B99E-C139AC2C85C4Q41686228-57377C44-2A86-4F92-83FA-B8054845DD68Q43055364-EE7E243E-A0C3-4184-8986-3B1C3B84C5B0Q43086789-3D75CADE-682F-4C49-A3CC-EF601F8C1CC7Q46466507-CF7232C0-2CBF-40AB-8D34-FE6F4A4ABF77
P2860
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@en
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@nl
type
label
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@en
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@nl
prefLabel
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@en
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@nl
P2093
P2860
P1476
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
@en
P2093
Anita Deswal
Biykem Bozkurt
David Aguilar
Kumudha Ramasubbu
P2860
P304
P356
10.1016/J.JACC.2009.04.049
P407
P577
2009-07-01T00:00:00Z